An open-label trial of aripiprazole in children and adolescents with bipolar disorder
Phase of Trial: Phase III
Latest Information Update: 26 Jun 2013
At a glance
- Drugs Aripiprazole (Primary)
- Indications Bipolar I disorders
- Focus Pharmacogenomic; Therapeutic Use
- 13 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Feb 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 18 Dec 2007 The expected completion date for this trial is 1 Jul 2009.